SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-013398
Filing Date
2022-08-12
Accepted
2022-08-12 07:17:44
Documents
89
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q aplt-20220630x10q.htm   iXBRL 10-Q 2192037
2 EX-31.1 aplt-20220630xex31d1.htm EX-31.1 9716
3 EX-31.2 aplt-20220630xex31d2.htm EX-31.2 9714
4 EX-32.1 aplt-20220630xex32d1.htm EX-32.1 6234
5 EX-32.2 aplt-20220630xex32d2.htm EX-32.2 6388
  Complete submission text file 0001558370-22-013398.txt   8939179

Data Files

Seq Description Document Type Size
6 EX-101.SCH aplt-20220630.xsd EX-101.SCH 70237
7 EX-101.CAL aplt-20220630_cal.xml EX-101.CAL 57784
8 EX-101.DEF aplt-20220630_def.xml EX-101.DEF 275891
9 EX-101.LAB aplt-20220630_lab.xml EX-101.LAB 541651
10 EX-101.PRE aplt-20220630_pre.xml EX-101.PRE 478392
83 EXTRACTED XBRL INSTANCE DOCUMENT aplt-20220630x10q_htm.xml XML 1522616
Mailing Address 545 5TH AVENUE, SUITE 1400 NEW YORK NY 10017
Business Address 545 5TH AVENUE, SUITE 1400 NEW YORK NY 10017 212-220-9319
Applied Therapeutics Inc. (Filer) CIK: 0001697532 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38898 | Film No.: 221157805
SIC: 2834 Pharmaceutical Preparations